Terms: = Liver cancer AND RUNX1T1, ENSG00000079102, 862 AND Prognosis
18 results:
1. A multivariate model based on gadoxetic acid-enhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dual‑phenotype hepatocellular carcinoma.
Liu MT; Zhang JY; Xu L; Qu Q; Lu MT; Jiang JF; Zhao XC; Zhang XQ; Zhang T
Radiol Med; 2023 Nov; 128(11):1333-1346. PubMed ID: 37740839
[TBL] [Abstract] [Full Text] [Related]
2. [The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
Zhang PR; Ma XL; Guo L; Lu RQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
[No Abstract] [Full Text] [Related]
3. Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma.
Yang R; Yu X; Zeng P
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10099-10108. PubMed ID: 37266663
[TBL] [Abstract] [Full Text] [Related]
4. Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium-Enhanced MRI.
Chen FM; Du M; Qi X; Bian L; Wu D; Zhang SL; Wang J; Zhou Y; Zhu X
J Magn Reson Imaging; 2023 Jun; 57(6):1893-1905. PubMed ID: 36259347
[TBL] [Abstract] [Full Text] [Related]
5. The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.
Ke Q; Xin F; Fang H; Zeng Y; Wang L; Liu J
Front Immunol; 2022; 13():913464. PubMed ID: 35677059
[TBL] [Abstract] [Full Text] [Related]
6. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic cancer: A Population-Based Analysis.
Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
[TBL] [Abstract] [Full Text] [Related]
7. Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
Jiang H; Song B; Qin Y; Chen J; Xiao D; Ha HI; Liu X; Oloruntoba-Sanders O; Erkanli A; Muir AJ; Bashir MR
Eur Radiol; 2021 Jun; 31(6):3638-3648. PubMed ID: 33245494
[TBL] [Abstract] [Full Text] [Related]
8. Single-nucleotide polymorphisms in the coding region of a disintegrin and metalloproteinase with thrombospondin motifs 4 and hepatocellular carcinoma: A retrospective case-control study.
Wang XZ; Tang WZ; Su QY; Yao JG; Huang XY; Long QQ; Wu XM; Xia Q; Long XD
Cancer Med; 2019 Dec; 8(18):7869-7880. PubMed ID: 31663692
[TBL] [Abstract] [Full Text] [Related]
9. Resection Combined with TKI Therapy for Resectable liver Metastases of Gastrointestinal Stromal Tumours: Results from Three National Centres in China.
Chen Q; Li C; Yang H; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Cai J; Zhou J
J Gastrointest Surg; 2020 Jun; 24(6):1330-1341. PubMed ID: 31187396
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection.
He Y; Mao M; Shi W; He Z; Zhang L; Wang X
J Transl Med; 2019 Mar; 17(1):98. PubMed ID: 30909980
[TBL] [Abstract] [Full Text] [Related]
11. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
12. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
[TBL] [Abstract] [Full Text] [Related]
13. Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.
Kaibori M; Yoshii K; Hasegawa K; Ogawa A; Kubo S; Tateishi R; Izumi N; Kadoya M; Kudo M; Kumada T; Sakamoto M; Nakashima O; Matsuyama Y; Takayama T; Kokudo N;
Ann Surg; 2019 Jul; 270(1):121-130. PubMed ID: 29608544
[TBL] [Abstract] [Full Text] [Related]
14. Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma.
Mustafa MZ; Nguyen VH; Le Naour F; De Martin E; Beleoken E; Guettier C; Johanet C; Samuel D; Duclos-Vallee JC; Ballot E
J Transl Med; 2016 Jan; 14():17. PubMed ID: 26774260
[TBL] [Abstract] [Full Text] [Related]
15. LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.
Wang CH; Li M; Liu LL; Zhou RY; Fu J; Zhang CZ; Yun JP
Oncotarget; 2015 Dec; 6(39):42118-29. PubMed ID: 26517349
[TBL] [Abstract] [Full Text] [Related]
16. Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Huang XY; Yao JG; Liao P; Tang YJ; Ma Y; Xia Q
Mol Carcinog; 2016 Jun; 55(6):1060-72. PubMed ID: 26152337
[TBL] [Abstract] [Full Text] [Related]
17. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation.
Yamashita Y; Yoshida Y; Kurihara T; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Uchiyama H; Shirabe K; Maehara Y
Liver Transpl; 2015 Jul; 21(7):961-8. PubMed ID: 25772591
[TBL] [Abstract] [Full Text] [Related]
18. Significance of palliative gastrectomy for late-stage gastric cancer patients.
Chen S; Li YF; Feng XY; Zhou ZW; Yuan XH; Chen YB
J Surg Oncol; 2012 Dec; 106(7):862-71. PubMed ID: 22648960
[TBL] [Abstract] [Full Text] [Related]
